Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Subject Population”

7 trials

Showing 7 of 7 results

Early research (Phase 1)Study completedNCT01764594
What this trial is testing

Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Immune System DiseasesAutoimmune DiseasesLupus Erythematosus, Systemic+2 more
UCB Pharma 24
Post-approval studies (Phase 4)Study completedNCT00808769
What this trial is testing

Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

Who this might be right for
Normal Healthy Subject Population
Procter and Gamble 30
Not applicableStudy completedNCT01899222
What this trial is testing

Assessment of Prototype Hand-Held Fundus Camera

Who this might be right for
Normal Subject Population
University of Rochester 8
Early research (Phase 1)Study completedNCT01449513
What this trial is testing

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy

Who this might be right for
Actinic Keratosis
LEO Pharma 24
Post-approval studies (Phase 4)Study completedNCT00903448
What this trial is testing

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Who this might be right for
Healthy
Procter and Gamble 40
Early research (Phase 1)UnknownNCT02467790
What this trial is testing

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation